|New findings from University of North Carolina-led HIV prevention study, HPTN 052|
|Monday, July 18, 2011|
Researchers from the University of North Carolina at Chapel Hill School of Medicine are presenting detailed data from the landmark HIV Prevention Trials Network (HPTN) 052 study today at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. The HPTN 052 study found that early treatment of HIV-infected people with combination antiretroviral therapy (cART) led to a 96 percent reduction in transmission of the the virus to their uninfected partners.
Today's presentation of the HPTN 052 results will include new data indicating that the protective benefit of early cART treatment may be even stronger than initially reported. "This study represents the culmination of many years of work, and we are thrilled by its success and by the opportunity to share these data with our colleagues and the public," said Dr. Myron Cohen, J. Herbert Bate Distinguished Professor of Medicine at UNC and principal investigator of the study.
For full release